Skip to main content

Ipca’s Primaquine pediatric products prequalified

News
23 September, 2026 - 00:12 (CEST)
Announcement
M

WHO Prequalification Unit (PQT) added the below new products to its prequalified list:

  • MA206 Primaquine (as phosphate) Tablets 2.5 mg – Ipca, India
  • MA207 Primaquine (as phosphate) Tablets 5 mg – Ipca, India
  • MA208 Primaquine (as phosphate) Tablets 7.5 mg – Ipca, India 

These products are used in the prevention of relapse of Plasmodium vivax and Plasmodium ovale malaria